Screener
aTyr Pharma ATYR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's total equity?
- aTyr Pharma (ATYR) reported total equity of $48.79M in Q2 2026.
- How has aTyr Pharma's total equity changed year-over-year?
- aTyr Pharma's total equity decreased by 34.8% year-over-year, from $74.85M to $48.79M.
- What is the long-term trend for aTyr Pharma's total equity?
- Over 5 years (2020 to 2025), aTyr Pharma's total equity has grown at a 16.3% compound annual growth rate (CAGR), from $31.65M to $67.48M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about aTyr Pharma's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude